Proyectos de ley › 90.ª Asamblea General
Relating to a focused review of Iowa cancer surveillance data, and making an appropriation
Temas:State budgetHealth care
Dónde está ahora
- Hecho: Presentado6 de febrero de 2024
- Se detuvo: SubcomitéMurió al terminar la Asamblea General
- Sigue: Comité de la Cámara
- Sigue: Lo aprueba la Cámara
- Sigue: Comité del Senado
- Sigue: Lo aprueba el Senado
- Sigue: A gobernador(a)
- Sigue: Firmado como ley
Murió al terminar la sesión La sesión de 2024 terminó el 19 de abril de 2024, la última sesión ordinaria de la Asamblea General. Los proyectos que no pasaron por ambas cámaras murieron. ¿Qué es el embudo (funnel)?
Qué contiene
Resumen con IA Iowa will provide $2 million to the department of health and human services to study why cancer rates are rising in the state. Experts will look at health data and work with the Iowa cancer consortium to suggest new ways to control the disease. The department must then give a report of their findings and recommendations to the legislature by September 2025. (Todavía no está traducido al español.)1
Lea la explicación oficial (en inglés)
This bill relates to a focused review of Iowa cancer surveillance data. The bill appropriates $2 million from the general fund of the state to the department of health and human services (HHS) for FY 2024-2025 to perform a focused review of Iowa cancer surveillance data. The bill directs HHS to collaborate with the Iowa cancer consortium to perform a focused review of the cancer incidence data collected in the state health registry of Iowa/Iowa cancer registry and the 2023-2027 Iowa cancer plan to investigate the causality of the increased incidence of cancer in Iowa and to recommend strategies and specific action steps, including policy changes, to guide cancer control activities. HHS shall utilize a portion of the moneys appropriated to employ one full-time equivalent position dedicated to the Iowa cancer control program and a portion to employ or engage staff with expertise in epidemiology, biostatistics, and other appropriate specialty areas to perform the review and develop the recommendations. HHS shall submit a report of the findings and recommendations resulting from the focused review to the general assembly by September 1, 2025.
Cabildeo
4 a favor · 0 en contra · 3 indecisos · Quiénes →